Max Healthcare Institute MAXHEALTH
One of India's largest hospital chains, focused on north India and expanding beds fast
Mapped in 1 theme: Nifty 50.
Index membership
Max Healthcare Institute is in the Nifty 50 (NSE industry: Healthcare).
Revenue and profit
| ₹ Cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 5,406 | 7,028 | 8,373 |
| Net profit | 1,058 | 1,076 | 1,442 |
Latest-year revenue ₹8,373 Cr (FY26, company-wide). Wider screens show FY22 onwards.
Strengths
- High revenue per bed and strong margins
- Large pipeline of new beds in big cities
Risks
- New beds dilute margins as they ramp up
- Rich valuation
Common questions
What does Max Healthcare Institute do?
One of India's largest hospital chains, focused on north India and expanding beds fast.
Which industry is Max Healthcare Institute in?
Healthcare, in the Nifty 50.
Who are Max Healthcare Institute's peers?
In the Nifty 50's Healthcare industry: Sun Pharmaceutical Industries, Cipla, Apollo Hospitals Enterprise and Dr. Reddy's Laboratories.
What is Max Healthcare Institute's market cap and valuation?
As of 30 Oct 2026: market cap ₹83,675 Cr, P/E 58.9x, ROCE 14.7%, ROE 14.7%, dividend yield 0.23%.